Eye screening that reached a million people.

Dates and assessment

Source published

2026-09-23

Bright published

2026-09-27

Substantive update

None recorded

Evidence state

Deployed

Independent verification

Not established by this source review

Last source review

2026-09-27

The claim in context

The human problem

Diabetic retinopathy can be caught early with screening, but many people never get a timely eye exam.

The prior constraint

A screening tool that works in one hospital does not automatically work across different health systems and countries.

AI’s actual role

A deep-learning tool read retinal images to flag people who needed a specialist referral, deployed across three health systems.

The documented result

A Nature Medicine Comment reports the tool was deployed across Aravind Eye Care System (India), Rajavithi Hospital (Thailand) and Lions Outback Vision (Australia), screening over one million patients, and draws cross-cutting lessons for scaling healthcare AI.

Why it may matter

It shows the human work behind scaling a medical AI — across clinics, countries and workflows — rather than a single accuracy figure.

Limitations

• This is a Comment reflecting on deployment, not a new controlled trial, and the work was funded by Alphabet Inc. with several authors employed by Alphabet; the lessons are the authors’ own account, not independent evaluation.

Original evidence

• Practical lessons in the global scaling of clinical AI: from one hospital to over a million patients screened · Nature Medicine · paper

Attribution

Credit Bright AI Future and link the canonical Bright record.

• Link to the canonical Bright record.
• Keep material limitations with the claim they qualify.
• Link to the original evidence when repeating a substantive claim.
• Do not describe a source check or organization-reported result as independent verification.

Linked source material, quotations, trademarks and media remain subject to their owners’ terms. No reuse right is granted for third-party media.